Parallel Advisors’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.15K | Buy |
155
+56
| +57% | +$1.67K | ﹤0.01% | 3020 |
|
|
2025
Q4 | $2.95K | Hold |
99
| – | – | ﹤0.01% | 3020 |
|
|
2025
Q3 | $3.58K | Buy |
99
+30
| +43% | +$988 | ﹤0.01% | 2906 |
|
|
2025
Q2 | $2.48K | Sell |
69
-48
| -41% | -$1.79K | ﹤0.01% | 2988 |
|
|
2025
Q1 | $4.61K | Buy |
117
+27
| +30% | +$908 | ﹤0.01% | 2710 |
|
|
2024
Q4 | $2.71K | Sell |
90
-9
| -9% | -$258 | ﹤0.01% | 2864 |
|
|
2024
Q3 | $2.32K | Buy |
99
+55
| +125% | +$1.2K | ﹤0.01% | 2853 |
|
|
2024
Q2 | $783 | Buy |
+44
| New | +$702 | ﹤0.01% | 3017 |
|
|
2024
Q1 | – | Sell |
-435
| Closed | -$7.43K | – | 3424 |
|
|
2023
Q4 | $7.43K | Hold |
435
| – | – | ﹤0.01% | 2396 |
|
|
2023
Q3 | $3.64K | Hold |
435
| – | – | ﹤0.01% | 2613 |
|
|
2023
Q2 | $10.8K | Hold |
435
| – | – | ﹤0.01% | 2140 |
|
|
2023
Q1 | $6.54K | Hold |
435
| – | – | ﹤0.01% | 2313 |
|
|
2022
Q4 | $5.15K | Hold |
435
| – | – | ﹤0.01% | 2319 |
|
|
2022
Q3 | $3K | Hold |
435
| – | – | ﹤0.01% | 2535 |
|
|
2022
Q2 | $2K | Buy |
+435
| New | +$2.72K | ﹤0.01% | 2645 |
|
|
2022
Q1 | – | Sell |
-528
| Closed | -$10K | – | 3288 |
|
|
2021
Q4 | $10K | Buy |
528
+478
| +956% | +$12.4K | ﹤0.01% | 2129 |
|
|
2021
Q3 | $2K | Hold |
50
| – | – | ﹤0.01% | 2739 |
|
|
2021
Q2 | $2K | Sell |
50
-14
| -22% | -$550 | ﹤0.01% | 2616 |
|
|
2021
Q1 | $3K | Hold |
64
| – | – | ﹤0.01% | 2408 |
|
|
2020
Q4 | $3K | Buy |
64
+19
| +42% | +$642 | ﹤0.01% | 2225 |
|
|
2020
Q3 | $1K | Hold |
45
| – | – | ﹤0.01% | 2496 |
|
|
2020
Q2 | $0 | Buy |
+45
| New | +$725 | ﹤0.01% | 2716 |
|
Other funds holding TGTX
VPM
VCM
SCM
CAM
